MCID: MYL001
MIFTS: 51

Myelitis malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Myelitis

About this section

Aliases & Descriptions for Myelitis:

Name: Myelitis 11 48 50 39 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:322
MeSH39 D009187
NCIt45 C26832

Summaries for Myelitis

About this section
Disease Ontology:11 A spinal cord disease that is characterized by inflammation of the white matter or gray matter of the spinal cord.

MalaCards based summary: Myelitis is related to hepatitis and meningitis. An important gene associated with Myelitis is AQP4 (Aquaporin 4), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and Transcription factor regulation in adipogenesis. Affiliated tissues include spinal cord, brain and lung, and related mouse phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and digestive/alimentary.

Wikipedia:71 Myelitis involves the infection or the inflammation of the white matter or gray matter of the spinal... more...

Related Diseases for Myelitis

About this section

Diseases related to Myelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 396)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis30.2IL10, IL6, TNF
2meningitis30.1CXCL8, IL6, TNF
3neuropathy30.0CXCL8, IL6, TNF
4tuberculosis29.5IL10, IL17A, IL6, TNF
5dermatitis herpetiformis29.3IL17A, TNF
6crest syndrome29.3AQP4, MBP
7colon adenocarcinoma29.0CXCL8, IL10, IL6, TNF
8pulmonary eosinophilia29.0CXCL8, IL10, IL6, TNF
9rheumatoid arthritis28.7CXCL8, HLA-DPB1, IL10, IL17A, IL6, TNF
10transverse myelitis12.4
11acute flaccid myelitis12.2
12acute transverse myelitis12.1
13idiopathic acute transverse myelitis12.0
14secondary acute transverse myelitis11.9
15radiation myelitis11.9
16neuromyelitis optica11.4
17foix-alajouanine syndrome11.3
18antiphospholipid syndrome11.1
19spinal cord disease10.8
20encephalitis10.5
21acute disseminated encephalomyelitis10.4
22tropical spastic paraparesis10.3
23stiff-person syndrome10.3
24vps11-related autosomal recessive hypomyelinating leukodystrophy10.3IL6, TNF
25supraumbilical midabdominal raphe and facial cavernous hemangiomas10.3APOH, IL6
26systemic lupus erythematosus10.3
27lupus erythematosus10.3
28dyslexia 510.3IL6, TNF
29aortic atherosclerosis10.3IL6, TNF
30degenerative disc disease10.3IL6, TNF
31pyridoxal 5'-phosphate-dependent epilepsy10.2IL10, TNF
32atherosclerosis10.2APOH, IL6
33ureter inverted papilloma10.2IL10, IL6
34unilateral multicystic dysplastic kidney10.2IL6, TNF
35tubular renal disease-cardiomyopathy syndrome10.2IL10, TNF
36oculomotor nerve paralysis10.2CXCL8, IL6
37meningoencephalitis10.2
38nguyen syndrome10.2IL10, IL17A
39common peroneal nerve lesion10.2CXCL8, IL6
40lagophthalmos10.2IL10, TNF
41multiple vertebral anomalies unusual facies10.2IL10, TNF
42swine influenza10.2IL6, TNF
43primary non-gestational choriocarcinoma of ovary10.2CXCL8, IL17A
44drug dependence10.2IL6, TNF
45childhood brainstem astrocytoma10.2AQP4, MBP
46endosalpingiosis10.2IL10, TNF
47uterine corpus cancer10.2APOH, AQP4, TNF
48psychotic disorder10.2CXCL8, IL6
49autoimmune disease of central nervous system10.2APOH, IL6, TNF
50severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive10.2IL10, TNF

Graphical network of the top 20 diseases related to Myelitis:



Diseases related to myelitis

Symptoms & Phenotypes for Myelitis

About this section

GenomeRNAi Phenotypes related to Myelitis according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00250-A-18.6APOH, CXCL8, IL10, IL17A, TNF

MGI Mouse Phenotypes related to Myelitis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.9AQP4, IL10, IL17A, IL6, IL9, TNF
2MP:00053888.7AQP4, IL10, IL17A, IL6, MMP2, TNF
3MP:00053977.8AQP4, IL10, IL17A, IL6, IL9, MBP
4MP:00053877.8AQP4, IL10, IL17A, IL6, IL9, MBP
5MP:00053917.8AQP4, IL10, IL6, MBP, MMP2, TNF
6MP:00053767.5APOH, AQP4, IL10, IL17A, IL6, IL9

Drugs & Therapeutics for Myelitis

About this section

Drugs for Myelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 158)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Prednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 1, Phase 2119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
2
Mitoxantroneapproved, investigationalPhase 427265271-80-94212
Synonyms:
1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone
1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon
1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
137635-96-2
2fum
5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone
65271-80-9
70476-82-3
70476-82-3 (hydrochloride)
70711-41-0
70711-41-0 (acetate)
70945-62-9
9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI)
AB00053716
AC1L1HNY
AN-584/42007670
BIDD:PXR0181
BPBio1_000627
BRD-K21680192-300-05-2
BRD-K21680192-300-07-8
BRN 2795126
BSPBio_000569
BSPBio_003160
C11195
C22H28N4O6
CAS-70476-82-3
CCRIS 7604
CHEBI:50729
CHEMBL58
CID4212
D08224
DB01204
DHAD
DHAQ
DHAQ (*Diacetate salt*)
DHAQ HCl
Dihydroxyanthraquinone
DivK1c_000516
HMS2090D05
IDI1_000516
KBio1_000516
KBio2_002135
KBio2_004703
KBio2_007271
KBio3_002660
KBioGR_001531
KBioSS_002135
LS-20638
Liposome Encapsulated Mitoxantrone (LEM)
Lopac-M-6545
Lopac0_000779
MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE
MIX
 
MLS002703044
Misostol
Misostol (TN)
Mitox
Mitoxanthrone
Mitoxantron
Mitoxantrona
Mitoxantrona [INN-Spanish]
Mitoxantrone
Mitoxantrone (INN)
Mitoxantrone (free base)
Mitoxantrone 2HCl
Mitoxantrone HCl
Mitoxantrone [INN]
Mitoxantrone dihydrochloride
Mitoxantrone hydrochloride
Mitoxantronum
Mitoxantronum [INN-Latin]
Mitozantrone
Mitozantrone hydrochloride
MolPort-003-849-239
NCGC00015693-01
NCGC00015693-02
NCGC00015693-04
NCGC00162251-01
NCI60_002276
NCI60_002535
NChemBio.2007.10-comp17
NINDS_000516
NSC 279836
NSC-279836
NSC-287836
NSC-299195
NSC-301739
NSC-301739D
NSC279836
NSC299195
NSC301739
Neuro_000153
Novantron
Novantrone
Novantrone(R) (mitoxantrone for injection concentrate)
Prestwick0_000385
Prestwick1_000385
Prestwick2_000385
Prestwick3_000385
S2485_Selleck
SMP2_000179
SMR001549953
SPBio_000756
SPBio_002490
SR-01000076001
SR-01000076001-7
STK631833
Spectrum2_000908
Spectrum3_001590
Spectrum4_000866
Spectrum5_001205
Spectrum_001655
UNII-BZ114NVM5P
VU0244399-2
mitoxantrone
3
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 1, Phase 2119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
4
ZincapprovedPhase 422967440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
5
Interferon beta-1aapproved, investigationalPhase 4, Phase 2200145258-61-36438354
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Belerofon
D04554
 
Fibroblast interferon
IFN-beta
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (USAN)
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
6Zinc sulfateapprovedPhase 4717733-02-0
7
IronapprovedPhase 4, Phase 3, Phase 211657439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
8
Edetic Acidapproved, vet_approvedPhase 4, Phase 3, Phase 29960-00-4, 62-33-96049
Synonyms:
(ethylenedinitrilo)tetraacetic acid, ion(4−)
2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
Acide ethylenediaminetetracetique
Acido edetico
Acidum edeticum
CaEDTA
Calcium Disodium Edetate (JAN)
Calcium Disodium Versenate
Calcium disodium versenate (TN)
 
EDT
EDTA
EDTA, ion(4-)
Edetate Calcium
Edetate calcium disodium (USP)
Ethylenediaminetetraacetate
Ethylenediaminetetraacetic acid
N,N'-1,2-Ethane diylbis-(N-(carboxymethyl)glycine)
acide edetique
{[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic acid
9
Mycophenolate mofetilapproved, investigationalPhase 4952128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
10
Prednisoneapproved, vet_approvedPhase 4139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
11
Mycophenolic acidapprovedPhase 495224280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
12
Phenolapproved, experimentalPhase 449108-95-2996
Synonyms:
Acide carbolique
Acide phenique
Anbesol
Benzenol
Benzophenol
Campho-phenique cold sore gel
Campho-phenique gel
Campho-phenique liquid
Carbolic acid
Carbolic acid liquid
Carbolic oil
Carbolicum acidum
Carbolsaeure
Carbolsaure
Cepastat lozenges
Cuticura pain relieving ointment
Fenol
Fenolo
Fenosmolin
Fenosmoline
Hydroxy-benzene
Hydroxybenzene
IPH
IZAL
Karbolsaeure
Liquefied phenol
Liquid phenol
Liquified phenol
 
Monohydroxy benzene
Monohydroxybenzene
Monophenol
Oxybenzene
PHOH
Paoscle
Phenic
Phenic Acid
Phenic acid
Phenic alcohol
Phenol
Phenol alcohol
Phenol homopolymer
Phenol liquid
Phenol molten
Phenol polymer-bound
Phenol solution
Phenol synthetic
Phenolated water
Phenolated water for disinfection
Phenole
Phenosmolin
Phenyl alcohol
Phenyl hydroxide
Phenylic Acid
Phenylic acid
Phenylic alcohol
Synthetic phenol
Tea polyphenol
13
Neomycinapproved, vet_approvedPhase 4501404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
 
Framygen
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
14ImmunoglobulinsPhase 4, Phase 3, Phase 2, Phase 16394
15Neuroprotective AgentsPhase 4, Phase 3, Phase 11716
16Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 1, Phase 21193
17Prednisolone acetatePhase 4, Phase 3, Phase 1, Phase 21193
18Prednisolone hemisuccinatePhase 4, Phase 3, Phase 1, Phase 21193
19Protective AgentsPhase 4, Phase 3, Phase 2, Phase 17443
20Prednisolone phosphatePhase 4, Phase 3, Phase 1, Phase 21193
21AnalgesicsPhase 411733
22Methylprednisolone acetatePhase 4, Phase 3, Phase 1, Phase 21193
23AntiemeticsPhase 4, Phase 3, Phase 14022
24Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 110729
25VaccinesPhase 4, Phase 3, Phase 2, Phase 16611
26Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 123689
27Topoisomerase InhibitorsPhase 45069
28AntibodiesPhase 4, Phase 3, Phase 2, Phase 16394
29Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 15592
30Hormone AntagonistsPhase 4, Phase 3, Phase 113180
31HormonesPhase 4, Phase 3, Phase 114415
32Autonomic AgentsPhase 4, Phase 3, Phase 110150
33glucocorticoidsPhase 4, Phase 3, Phase 15103
34Gastrointestinal AgentsPhase 4, Phase 3, Phase 1, Phase 28402
35Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 113168
36Immunosuppressive AgentsPhase 4, Phase 2, Phase 3, Phase 113086
37Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2465
38PENTAPhase 4, Phase 3109
39Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 18192
40Fibrinolytic AgentsPhase 4, Phase 3, Phase 22388
41AntimetabolitesPhase 4, Phase 2, Phase 3, Early Phase 112054
42Antimetabolites, AntineoplasticPhase 4, Phase 2, Phase 37361
43Antirheumatic AgentsPhase 4, Phase 2, Phase 3, Phase 110956
44Dermatologic AgentsPhase 4, Phase 2, Phase 35806
45Nucleic Acid Synthesis InhibitorsPhase 4, Phase 2, Phase 3, Early Phase 14962
46Chelating AgentsPhase 4, Phase 3, Phase 21423
47interferonsPhase 4, Phase 22175
48MicronutrientsPhase 46001
49Interferon-betaPhase 4, Phase 2284
50Antiviral AgentsPhase 4, Phase 2, Phase 3, Early Phase 19967

Interventional clinical trials:

(show top 50)    (show all 221)
idNameStatusNCT IDPhase
1Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV VaccineUnknown statusNCT01841671Phase 4
2Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersUnknown statusNCT02021825Phase 4
3Long Term Study of Avonex Therapy Following a First Attack of Multiple SclerosisCompletedNCT00179478Phase 4
4A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)CompletedNCT00304291Phase 4
5Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
6Immunogenicity of Monovalent Type 2 Oral Poliovirus VaccineCompletedNCT02643368Phase 4
7Intestinal and Humoral Immunity of Sequential Polio Vaccination SchedulesCompletedNCT02412514Phase 4
8Polio End-game Strategies - Poliovirus Type 2 Challenge StudyCompletedNCT02189811Phase 4
9Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in JapanCompletedNCT02005536Phase 4
10IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
11Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineCompletedNCT01831050Phase 4
12IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.CompletedNCT01695798Phase 4
13Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus VaccinesCompletedNCT01616693Phase 4
14Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccineCompletedNCT01475539Phase 4
15A Safety Study of IMOVAX Polio Vaccine in Selected Cities in ChinaCompletedNCT01278433Phase 4
16A Study of the Safety of IMOVAX Polio™ in ChinaCompletedNCT01244464Phase 4
17Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in RussiaCompletedNCT01094171Phase 4
18Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRECompletedNCT01546909Phase 4
19Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CourseCompletedNCT01457547Phase 4
20Regulatory Post-Marketing Surveillance Study for TETRAXIM™CompletedNCT01437423Phase 4
21Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™CompletedNCT01358825Phase 4
22Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted AdultsCompletedNCT01323959Phase 4
23Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNCT01031303Phase 4
24Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in InfantsCompletedNCT00753649Phase 4
25Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio VaccineCompletedNCT00635128Phase 4
26Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old ChildrenCompletedNCT00611559Phase 4
27Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccineCompletedNCT00514059Phase 4
28Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy InfantsCompletedNCT00325156Phase 4
29Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineCompletedNCT00304265Phase 4
30Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedNCT00255021Phase 4
31Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryRecruitingNCT02853929Phase 4
32Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryRecruitingNCT02422264Phase 4
33Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus StudyActive, not recruitingNCT02847026Phase 4
34To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in PakistanActive, not recruitingNCT01908114Phase 4
35Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese PatientsEnrolling by invitationNCT02809079Phase 4
36A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in LithuaniaNot yet recruitingNCT02582255Phase 4
37A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of AgeNot yet recruitingNCT02580201Phase 4
38Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
39Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisoloneUnknown statusNCT00004645Phase 3
40Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans NewbornsUnknown statusNCT01870206Phase 3
41Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)Unknown statusNCT01343355Phase 2, Phase 3
42Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
43Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus VaccineCompletedNCT02785705Phase 3
44Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis VaccineCompletedNCT02434770Phase 3
45Immunogenicity of Intramuscular Inactivated Poliovirus VaccineCompletedNCT02291263Phase 3
46The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)CompletedNCT02231632Phase 2, Phase 3
47Immunogenicity of Inactivated and Live Polio VaccinesCompletedNCT01813604Phase 3
48The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)CompletedNCT01510366Phase 3
49Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in JapanCompletedNCT01389687Phase 3
50Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated ToddlersCompletedNCT01323647Phase 3

Search NIH Clinical Center for Myelitis


Cochrane evidence based reviews: myelitis

Genetic Tests for Myelitis

About this section

Anatomical Context for Myelitis

About this section

MalaCards organs/tissues related to Myelitis:

36
Spinal cord, Brain, Lung, Bone, Bone marrow, Breast, B cells

Publications for Myelitis

About this section

Articles related to Myelitis:

(show top 50)    (show all 927)
idTitleAuthorsYear
1
Acute myelitis resembling human T-lymphotropic virus type 1-associated myelopathy presenting as high-signal-intensity long cord lesions on T2-weighted magnetic resonance images combined with lymphoma-type adult T-cell leukemia/lymphoma. (27817856)
2017
2
Recall radiation myelitis after stereotactic radiation and dabrafenib in metastatic melanoma. (27830981)
2017
3
Comorbidity of narcolepsy with cataplexy and transverse myelitis: aA common autoimmune background? A case report. (28449899)
2017
4
Acute flaccid myelitis associated with enterovirus-D68 infection in an otherwise healthy child. (28081720)
2017
5
Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis. (27884934)
2017
6
Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders. (28067584)
2017
7
A Rare Infectious Cause of Transverse Myelitis. (28004628)
2017
8
Etiologic spectrum and functional outcome of the acute inflammatory myelitis. (28074391)
2017
9
Toxocara canis-Associated Myelitis with Eosinophilic Pneumonia. (27358582)
2016
10
Serological prevalence of celiac disease in Brazilian population of multiple sclerosis, neuromyelitis optica and myelitis. (27645359)
2016
11
Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience. (27480991)
2016
12
Transverse myelitis-like presentation of methanol intoxication: A case report and review of the literature. (27707395)
2016
13
Cervical Myelitis Presenting as Occipital Neuralgia. (28025377)
2016
14
Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders. (27616312)
2016
15
Transverse myelitis. (26882855)
2016
16
Cervical spinal cord atrophy in NMOSD without a history of myelitis or MRI-visible lesions. (27144215)
2016
17
Recognition and Management of Acute Flaccid Myelitis in Children. (26621554)
2016
18
Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India. (27348743)
2016
19
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus. (27157526)
2016
20
Longitudinal extensive transverse myelitis and Zika virus: A diagnostic challenge in a hospital in Colombia. (27776956)
2016
21
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients. (26857502)
2016
22
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past. (27003705)
2016
23
A pediatric patient of hemorrhagic acute transverse myelitis. (27686688)
2016
24
Longitudinal extensive transverse myelitis with cervical epidural haematoma following dengue virus infection. (26900103)
2016
25
Elevated Lipid Profiles in Patients with Acute Transverse Myelitis. (26949935)
2016
26
Teaching NeuroImages: Longitudinally extensive transverse myelitis in MELAS. (26810428)
2016
27
An Unusual Case of Myelitis with Myositis. (27437283)
2016
28
Enterovirus D68 Infection in Children with Acute Flaccid Myelitis, Colorado, USA, 2014. (27434186)
2016
29
Viral load and ganciclovir (GCV) concentration in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis/myelitis following umbilical cord blood transplantation. (27459097)
2016
30
Successful management of methicillin-resistant Staphylococcus aureus bacteremia complicated with diffuse myelitis. (27464005)
2016
31
Concomitant Guillain Barre Syndrome and Transverse Myelitis as Initial Neuropsychiatric Manifestation in a Case of Lupus: A Diagnostic Quandary. (27242943)
2016
32
Poster 463 Unexpected Transverse Myelitis after Dinutuximab Therapy for Relapsed Neuroblastoma: A Case Report. (27673209)
2016
33
Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists. (27450408)
2016
34
Leprous ganglionitis and myelitis. (27218117)
2016
35
Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD. (26723980)
2016
36
Post-Herpes zoster myelitis in a very old patient: A complication not to be missed. (27440114)
2016
37
Neuromyelitis optica spectrum initially diagnosed as antiphospholipid antibody myelitis. (26810544)
2016
38
An unusual case of acute transverse myelitis caused by HSV-1 infection. (27419072)
2016
39
Acute myelitis due to Zika virus infection. (26946926)
2016
40
A Case of Transverse Myelitis Caused by Varicella Zoster Virus in an Immunocompetent Older Patient. (27883372)
2016
41
Hemorrhagic Longitudinally Extensive Transverse Myelitis. (27847660)
2016
42
Rehabilitation of a patient with overlap of acute transverse myelitis and Bickerstaff's brainstem encephalitis: a case report. (28053734)
2016
43
Acute transverse myelitis of the cervical spine secondary to psoas abscess. (27756229)
2016
44
Transverse Myelitis as an Unusual Complication of Dengue Fever. (27956656)
2016
45
Myelitis: A Rare Neurological Complication of Herpes Zoster. (27904197)
2016
46
Idiopathic Transverse Myelitis Mimicking an Intramedullary Spinal Cord Tumor. (27672469)
2016
47
Acute myelitis by human herpes virus 7 in an HIV-infected patient. (26906233)
2016
48
Extensive myelitis revealing common variable immunodeficiency. (27374860)
2016
49
Acute Transverse Myelitis and Nicolau Syndrome after Benzathine Penicillin Injection. (27762530)
2016
50
Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome. (27734022)
2016

Variations for Myelitis

About this section

Expression for genes affiliated with Myelitis

About this section
Search GEO for disease gene expression data for Myelitis.

Pathways for genes affiliated with Myelitis

About this section

Pathways related to Myelitis according to GeneCards Suite gene sharing:

(show top 50)    (show all 51)
idSuper pathwaysScoreTop Affiliating Genes
19.8IL6, IL9
29.7IL6, TNF
39.4IL10, IL9
49.4HLA-DPB1, IL6, TNF
59.2CXCL8, TNF
69.2IL6, MMP2, TNF
79.2IL6, MMP2, TNF
89.2IL6, MMP2, TNF
9
Show member pathways
9.1IL10, IL6, IL9
109.1IL10, IL6, TNF
119.1IL10, IL6, TNF
129.1IL10, IL6, TNF
139.1IL10, IL6, TNF
149.1IL10, IL6, TNF
159.1IL10, IL6, TNF
16
Show member pathways
9.0CXCL8, IL17A, IL6
178.9IL17A, IL6, IL9, TNF
188.9CXCL8, IL6, TNF
19
Show member pathways
8.9CXCL8, IL6, TNF
208.9CXCL8, IL6, TNF
21
Show member pathways
8.9CXCL8, IL6, TNF
228.8CXCL8, IL6, MMP2
238.8CXCL8, IL6, MMP2
248.8CXCL8, IL6, MMP2
258.8HLA-DPB1, IL10, IL6, TNF
26
Show member pathways
8.7IL10, IL17A, IL6, TNF
278.6IL10, IL17A, IL9, TNF
28
Show member pathways
8.6CXCL8, HLA-DPB1, IL6, TNF
29
Show member pathways
8.5CXCL8, IL17A, IL6, TNF
30
Show member pathways
8.4HLA-DPB1, IL10, IL17A, IL6, TNF
318.4CXCL8, IL6, MMP2, TNF
32
Show member pathways
8.4CXCL8, IL6, MMP2, TNF
338.4CXCL8, IL6, MMP2, TNF
34
Show member pathways
8.3IL10, IL17A, IL6, IL9, TNF
358.3CXCL8, IL10, IL6, TNF
368.3CXCL8, IL10, IL6, TNF
378.3CXCL8, IL10, IL6, TNF
388.3CXCL8, IL10, IL6, TNF
398.2CXCL8, HLA-DPB1, IL17A, IL6, TNF
40
Show member pathways
8.2IL10, IL17A, IL6, MMP2, TNF
418.1AQP4, CXCL8, IL6, MBP, TNF
428.0AQP4, CXCL8, IL10, IL6, TNF
43
Show member pathways
7.5CXCL8, IL10, IL17A, IL6, IL9, TNF
44
Show member pathways
7.5CXCL8, IL10, IL17A, IL6, IL9, TNF
457.5CXCL8, IL10, IL17A, IL6, IL9, TNF
46
Show member pathways
7.5CXCL8, IL10, IL17A, IL6, IL9, TNF
47
Show member pathways
7.5CXCL8, IL10, IL17A, IL6, IL9, TNF
487.4CXCL8, IL10, IL17A, IL6, MMP2, TNF
49
Show member pathways
7.2CXCL8, HLA-DPB1, IL10, IL17A, IL6, IL9
50
Show member pathways
6.6CXCL8, HLA-DPB1, IL10, IL17A, IL6, IL9

GO Terms for genes affiliated with Myelitis

About this section

Cellular components related to Myelitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.8AQP4, IL17A, IL6, TNF
2extracellular regionGO:00055767.3APOH, CXCL8, IL10, IL17A, IL6, IL9
3extracellular spaceGO:00056156.6APOH, CXCL8, IL10, IL17A, IL6, IL9

Biological processes related to Myelitis according to GeneCards Suite gene sharing:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.4IL6, TNF
2negative regulation of lipid storageGO:001088810.3IL6, TNF
3positive regulation of chemokine productionGO:003272210.3IL6, TNF
4cellular response to hepatocyte growth factor stimulusGO:003572910.3IL10, IL6
5defense response to protozoanGO:004283210.3IL10, IL6
6positive regulation of osteoclast differentiationGO:004567210.2IL17A, TNF
7positive regulation of interleukin-6 secretionGO:200077810.2IL17A, MBP
8endothelial cell apoptotic processGO:007257710.1IL10, TNF
9negative regulation of cytokine secretion involved in immune responseGO:000274010.0IL10, TNF
10negative regulation of growth of symbiont in hostGO:004413010.0IL10, TNF
11negative regulation of interleukin-6 productionGO:003271510.0IL10, TNF
12negative regulation of mitotic cell cycleGO:004593010.0IL10, TNF
13positive regulation of heterotypic cell-cell adhesionGO:003411610.0IL10, TNF
14negative regulation of heterotypic cell-cell adhesionGO:003411510.0IL10, MBP
15embryonic digestive tract developmentGO:00485669.9CXCL8, TNF
16receptor biosynthetic processGO:00328009.9IL10, TNF
17cellular response to interleukin-1GO:00713479.7CXCL8, IL17A, IL6
18positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.6IL10, IL6, TNF
19positive regulation of vascular smooth muscle cell proliferationGO:19047079.4IL10, MMP2, TNF
20response to glucocorticoidGO:00513849.4IL10, IL6, TNF
21response to molecule of bacterial originGO:00022379.0CXCL8, IL10
22cellular response to lipopolysaccharideGO:00712229.0CXCL8, IL10, IL6, TNF
23inflammatory responseGO:00069548.1CXCL8, IL10, IL17A, IL6, IL9, TNF
24immune responseGO:00069557.3CXCL8, HLA-DPB1, IL10, IL17A, IL6, IL9

Molecular functions related to Myelitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1growth factor activityGO:00080839.1IL10, IL6, IL9
2cytokine activityGO:00051258.1CXCL8, IL10, IL17A, IL6, IL9, TNF

Sources for Myelitis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet